06:57 AM EST, 11/06/2024 (MT Newswires) -- Enovis ( ENOV ) reported fiscal Q3 adjusted earnings Wednesday of $0.73 per diluted share, up from $0.56 a year earlier.

Analysts polled by Capital IQ expected $0.61.

Net sales for the quarter ended Sept. 27 were $505.2 million, up from $417.5 million a year earlier.

Analysts surveyed by Capital IQ expected $504.5 million.

The medical technology firm said it now expects fiscal 2024 adjusted EPS of $2.75 to $2.80, up from its previous guidance of $2.62 to $2.77. Analysts polled by Capital IQ expect $2.70.

Revenue for the fiscal year is now projected to be $2.10 billion, the company said. That compares with a range of $2.08 billion to $2.13 billion projected previously. Analysts surveyed by Capital IQ expect $2.11 billion.

Shares of the company were up more than 3% in recent premarket activity on Wednesday.

Price: 44.62, Change: +1.31, Percent Change: +3.02